Skip to main content
buildings in chicago

Location

Chicago, Illinois

Schedule a Meeting

Date

May 31 2024 - Jun 04 2024
Expired!

Participation

Booth #26149

ASCO (American Society of Clinical Oncology) 2024

Join the TFS HealthScience team at the ASCO 2024 Annual Meeting in Chicago, IL from May 31-June 4.

Meet our seasoned team of oncology & hematology experts attending the conference. You can stop by Booth #26149 to learn how to run accelerated clinical trials efficiently and effectively!

Our oncology & hematology team excels in managing clinical development Phases I-IV and patient recruitment across multiple indications. We pride ourselves on partnering with sponsors to develop a regulatory and operational strategy tailored to your specific trial’s requirements.

Why TFS in Oncology & Hematology?

Experience scientific and medical excellence in oncology & hematology. Our team delivers all the scientific and medical aspects of your clinical program to help ensure market success. We provide support in site start-up, patient access, referral, recruitment and retention, and investigator identification at global, regional, and local levels. With our internal experts and global network of key opinion leaders (KOLs), we ensure a comprehensive approach to your dermatology trials.

Click here to learn more about our oncology & hematology services!

Our Experts

Bin Pan

Bin Pan

Executive Director and Head of Hematology/Oncology

Estelle Guiheneuf

Estelle Guiheneuf

Director, Project Management

Tabitha Schlisserman

Tabitha Schlisserman

Director, Business Development

Portion King

Portion King

Director, Business Development

Mike Coon

Mike Coon

Director, Business Development

Joanna Burns

Joanna Burns

Director, Business Development

Mike Mendoza

Mike Mendoza

Executive Director, eClinical Technology Strategy and Biometrics

Contact us today to connect during the conference and discover how TFS can be your strategic CRO partner in oncology & hematology clinical development. See you at ASCO (American Society of Clinical Oncology) 2024!